CLRB Earnings Cellectar Biosciences, Inc.
Reported diluted EPS by fiscal period (SEC EDGAR). Chart & overview →
1–20 of 20
| Q1 2026 | 2026-03-31 | -1.33 | 2026-05-14 | 10-Q |
| FY 2025 | 2025-12-31 | -8.35 | 2026-03-04 | 10-K |
| Q3 2025 | 2025-09-30 | -7.82 | 2025-11-13 | 10-Q |
| Q2 2025 | 2025-06-30 | -7.66 | 2025-08-14 | 10-Q |
| Q1 2026 | 2025-03-31 | -4.30 | 2026-05-14 | 10-Q |
| FY 2025 | 2024-12-31 | -41.89 | 2026-03-04 | 10-K |
| Q3 2025 | 2024-09-30 | -41.79 | 2025-11-13 | 10-Q |
| Q2 2025 | 2024-06-30 | -25.38 | 2025-08-14 | 10-Q |
| Q1 2025 | 2024-03-31 | -0.91 | 2025-05-13 | 10-Q |
| FY 2024 | 2023-12-31 | -3.50 | 2025-03-13 | 10-K |
| Q3 2024 | 2023-09-30 | -3.09 | 2024-11-18 | 10-Q |
| Q2 2024 | 2023-06-30 | -1.54 | 2024-10-29 | 10-Q |
| Q1 2024 | 2023-03-31 | -0.76 | 2024-05-14 | 10-Q |
| FY 2023 | 2022-12-31 | -4.05 | 2024-03-27 | 10-K |
| Q3 2023 | 2022-09-30 | -3.50 | 2023-11-13 | 10-Q |
| Q2 2023 | 2022-06-30 | -2.22 | 2023-08-14 | 10-Q |
| Q1 2023 | 2022-03-31 | -1.00 | 2023-05-04 | 10-Q |
| FY 2022 | 2021-12-31 | -4.35 | 2023-03-09 | 10-K |
| Q3 2022 | 2021-09-30 | -3.39 | 2022-11-03 | 10-Q |
| Q2 2022 | 2021-06-30 | -2.45 | 2022-08-05 | 10-Q |
Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Informational only — not financial advice.